舒泰神股价涨5.65%,中信保诚基金旗下1只基金重仓,持有35.5万股浮盈赚取55.03万元

Group 1 - The core point of the news is that Shuyou Shen's stock price has increased by 5.65% on February 6, reaching 29.00 CNY per share, with a total market capitalization of 13.855 billion CNY and a trading volume of 437 million CNY, marking a cumulative increase of 10.2% over three consecutive days [1] - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. was established on August 16, 2002, and went public on April 15, 2011. The company primarily engages in the research, production, and sales of biological products and some chemical drugs [1] - The main revenue composition of Shuyou Shen includes 59.17% from injectable mouse nerve growth factor (Sutai Shen), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1] Group 2 - According to data, CITIC Prudential Fund has a significant holding in Shuyou Shen, with the CITIC Prudential Zhi Rui Mixed A Fund (003432) increasing its holdings by 60,000 shares in the fourth quarter, totaling 355,000 shares, which represents 4% of the fund's net value [2] - The fund has generated a floating profit of approximately 550,300 CNY today and a total of 901,700 CNY during the three-day increase [2] - The CITIC Prudential Zhi Rui Mixed A Fund was established on October 21, 2016, with a current size of 134 million CNY, and has achieved a year-to-date return of 0.45% [2]

Staidson BioPharm-舒泰神股价涨5.65%,中信保诚基金旗下1只基金重仓,持有35.5万股浮盈赚取55.03万元 - Reportify